TRIL
Trillium Therapeutics Inc.
TRIL
TRIL
Delisted
TRIL was delisted on the 16th of November, 2021.
33 hedge funds and large institutions have $44.8M invested in Trillium Therapeutics Inc. in 2015 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
36% less capital invested
Capital invested by funds: $69.9M → $44.8M (-$25.1M)
Holders
33
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$2.11M | |
| 2 | +$1.67M | |
| 3 | +$821K | |
| 4 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$652K |
| 5 |
Millennium Management
New York
|
+$295K |
Top Sellers
| 1 | -$2.57M | |
| 2 | -$785K | |
| 3 | -$436K | |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$425K |
| 5 |
DWM
Destination Wealth Management
Walnut Creek,
California
|
-$357K |